Lovaza®: Potent, pure, and proven?

Evidence-Based Practice

Volumn 11, Issue 3, 2008, Pages 10-11

  Baker, Nicole A ^a   Murdock, Nicole ^a   Pugmire, Brooke ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49249098574     PISSN: 10954120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (11)

1. Lovaza (omega-3 acid ethyl esters) capsules [prescribing information]. Liberty Corner, NJ: Reliant Pharmaceuticals, Inc; Revised August 2007. Available at: http://www.omacorrx.corn/downloads/ LOVAZA_prescribing_Info.pdf. Accessed February 21, 2008.
2. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 1997; 4:385-391.
3. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr 1980; 33:2657-266l.
4. Nambi V, Ballantyne CM. Combination therapy with statins and omega-3 fatty acids. Am J Cardiol. 2006; 98(4A):34i-38i.
5. Wang C, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on cardiovascular disease. Evid Rep Technol Assess (Full Rep) 2004 Mar; (94):1-122.
6. Jacobson TA. Secondary prevention of coronary artery disease with omega-3 fatty acids. Am J Cardiol. 2006; 98(4A):61i-70i:
7. Product review: Omega-3 latty acids (EPA & DHA) front fish/marine oils. Available at: http://www.consumerlab.com/results/omega3.asp. Last updated November 4, 2007. Accessed February 21, 2008.
8. Stalenghoef AF, de Graaf J, Wittekoek ME, Bredie SJ, Demacker PN, Kastelein JJ. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia. Atherosclerosis 2000; 153:129-138.
9. van Dam M, Stalenhoef AF, Wittekoek J, Trip MD, Prins MH, Kastelein JJP. Efficacy of concentrated n-3 fatty acids in hypertriglyceridaemia: a comparison with gemfibrozil. Clin Drug Invest 2001; 21:175-181.
10. Marchioli R, Barzi F, Bomba E, et al; for the GISSI-Prevenzione Investigators. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105:1847-1903.
11. Yokoyoma M. Effects of eicosapentaenoic acid (EPA) on major cardiovascular events in hypercholesterolemic patients: the Japan EPA Lipid Intervention Study (JELIS). Presented at: American Heart Association Scientific Sessions; November 14, 2005; Dallas, Tex.